sugammadex sodium
Also known as sugammadex octasodium salt, 6a,6b,6c,6d,6e,7f,6g,6h-octakis-s-(2-carboxyethyl)-6a,6b,6c,6d,6e,7f,6g,6h-octathio-gamma-cyclodextrin octasodium salt
Sugammadex, sold under the brand name Bridion, is a medication for the reversal of neuromuscular blockade induced by rocuronium and vecuronium in general anaesthesia. It is the first selective relaxant binding agent (SRBA). It is marketed by Merck.
Article
7 sectionsContents
- Medical uses
- Pharmacology
- Pharmacodynamics
- Efficacy
- Tolerability
- History
- References
Sugammadex, sold under the brand name Bridion, is a medication for the reversal of neuromuscular blockade induced by rocuronium and vecuronium in general anaesthesia. It is the first selective relaxant binding agent (SRBA). It is marketed by Merck.
The most common side effects include cough, airway problems due to the anaesthesia wearing off, reduced blood pressure and other complications such as changes in heart rate.
Gallery (2)
Connections
Categories
AnesthesiaChemical articles with multiple ChEBIsChemical articles with multiple PubChem CIDsChemicals using indexlabelsDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs developed by Merck & Co.Drugs with non-standard legal statusECHA InfoCard ID from WikidataMultiple chemicals in Infobox drugOligosaccharides